Immunological hurdles to lung gene therapy

Area of Science:

• Pulmonary Medicine
• Gene Therapy
• Immunology

Background:

• Gene delivery offers potential treatments for severe lung conditions like cystic fibrosis and lung cancer.
• Clinical trials confirm the feasibility and safety of lung gene transfer, yet expression remains inefficient.
• Both viral and non-viral gene delivery systems face challenges, including host immune responses.

Purpose of the Study:

• To review the immunological barriers affecting gene transfer to the lung.
• To discuss strategies for modulating the host immune system for gene therapy.
• To highlight limitations of current approaches and future directions.

Main Methods:

• Review of experimental animal and clinical trial data.
• Analysis of inflammatory, antibody, and T cell responses to gene transfer vectors.
• Examination of pharmacological and immunological agents for immune modulation.

Main Results:

• Host immune responses significantly limit transgene expression duration and vector re-administration.
• Inflammatory, antibody, and T cell responses are major barriers to successful lung gene transfer.
• Current strategies to modulate the immune system have limitations.

Conclusions:

• Understanding lung immunological barriers is crucial for improving gene therapy outcomes.
• Strategies are needed to achieve sustained transgene expression and enable vector re-administration.
• Further research into immune modulation can enhance the efficacy of gene therapy for lung diseases.